Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Carnifert is a multi-ingredient dietary supplement developed by Rowez Life Sciences, specifically formulated to support male reproductive health and address idiopathic male infertility. The product typically contains a synergistic blend of L-carnitine, acetyl-L-carnitine, L-arginine, glutathione, coenzyme Q10, and essential vitamins and minerals such as zinc and selenium. Its primary mechanism of action involves enhancing sperm mitochondrial energy metabolism, which is critical for sperm motility, and providing potent antioxidant protection to mitigate the damaging effects of reactive oxygen species (ROS) on sperm DNA and cell membranes. By improving sperm concentration, motility, and morphology, Carnifert is used to improve the chances of conception in men with conditions like oligospermia and asthenozoospermia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Carnifert.